期刊文献+

白细胞介素10基因启动子多态性与多发性硬化发病关系的meta分析

Association between interleukin-10 gene promoter polymorphisms and multiple sclerosis:a meta-analysis
下载PDF
导出
摘要 目的探讨白细胞介素10基因启动子多态性-1082G/A、-819C/T和-592C/A与多发性硬化(multiple sclerosis,MS)发病的关系。方法在PubMed、EBSCO、Ovid、EMbase、CNKI、万方科技与维普数据库中系统性检索1990年1月1日至2015年1月31日发表的相关文献,在等位基因、显性遗传、隐性遗传和共显性遗传4类模型下,合并OR值和95%CI,并行敏感性分析和发表偏倚评估。结果共纳入10篇文献,病例组1 483例,对照组1 796例。在所有模型中,-1082、-819位点基因分布在MS组与对照组间差异无统计学意义。但隐性遗传模型(AA vs GA+GG)显示复发缓解型+继发进展型MS亚组与对照组在-1082位点上的基因分布差异有统计学意义(OR=0.729,95%CI=0.534-0.995,P〈0.05)。等位基因模型(A vs C)(OR=0.825,95%CI=0.683-0.998,P〈0.05)、显性遗传模型(AA+CA vs CC)(OR=0.764,95%CI=0.605-0.966,P〈0.05)和杂合子模型(CA vs CC)(OR=0.750,95%CI=0.585-0.960,P〈0.05)表明MS组与对照组在-592位点上的基因分布差异有统计学意义。敏感性分析显示,除-819位点杂合子模型和-592位点等位基因模型结果不稳健外,3个位点各模型均稳健。未发现明显发表偏倚。结论 -1082位点AA基因型对复发缓解型及继发进展型MS的发生具有保护作用;-592位点CA基因型对MS的发生具有保护作用,而CC基因型携带者更易发生MS;-819位点CT基因型相对于CC基因型携带者可能不易发生MS。 Objective To explore the assosiction between interleukin-10(IL-10)gene promoter polymorphisms(-1082G/A,-592C/A and-892C/T)and multiple sclerosis(MS).Methods The data were collected from the Pubmed,EBSCO,Ovid,EMbase,CNKI library,WANFAN data and VIP,and the references of eligible studies were manually screened from Jan 1,1990 to Jan 31,2015.A standard meta-analysis approach was conducted on the associations between IL-10 promoter polymorphisms(-1082G/A,-592C/A and-892C/T)and MS using allele contrast,recessive,dominant,and co-dominant models.The combined odds ratio(OR)with 95%confidence interval(CI)was calculated to test heterogeneity and sensitivity analysis.Results A total of 10 studies involving 1 483 cases and 1 796 controls were considered in this meta-analysis.All the four models showed that neither the presence of genotypes nor the frequency of alleles differed significantly between MS patients and controls at-1082and-819 site.However,in subgroup analysis,the AA versus GA+GG genotype was significantly different between relapsingremitting(RR)/secondary-progressive(SP)MS patients and controls at-1082site(OR =0.729,95%CI =0.534-0.995,P 〈0.05).At-592 site,there were significant differences in the allele contrast(A vs C)(OR =0.825,95%CI =0.683-0.998,P 〈0.05),dominant(AA+CA vs CC)(OR =0.764,95%CI =0.605-0.966,P 〈0.05)and codominant(CA vs CC)(OR =0.750,95%CI =0.585-0.960,P 〈0.05)models.The sensitivity analysis showed the results were all stable except the presence of CT versus CC at-819 site and A versus C at-592 site.Conclusion The AA genotype at-1082 site was associated with the low risk of RRMS and SPMS.At-592 site,CA genotype was associated with the low risk of MS,while the patients with CC genotype were more likely to suffer from MS.The patients with CT genotype at-819 site might reduce the susceptibility of MS rather than CC genotype.
出处 《临床荟萃》 CAS 2015年第7期745-750,共6页 Clinical Focus
关键词 多发性硬化 多态性 单核苷酸 白细胞介素-10 疾病易感性 multiple sclerosis polymorphism single nucleotide interleukin-10 single nucleotide polymorphisms
  • 相关文献

参考文献26

  • 1Pravica V, Popadic D, Savic E, et al. Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers[J]. Immunol Res, 2012, 52 (1/2) :42-52.
  • 2Cheng Q, Cheng XJ, Jiang GX. Multiple sclerosis in China-- history and future[J].Mult Scler, 2009, 15(6) :655-660.
  • 3Das UN. Is multiple sclerosis a proresolution deficiency disorder? [J]. Nutrition, 2012, 28(10):951-958.
  • 4Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease[J]. Crit Rev Immunol, 2012, 32(1) :23-63.
  • 5de Jong BA, Westendorp RG, Eskdale J, et al. Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis[J]. Hum Immunol, 2002, 63(4):281-285.
  • 6Forte GI, Ragonese P, Salemi G, et al. Search for genetic factors associated with susceptibility to multiple sclerosis[J]: Ann N Y Acad Sci, 2006, 1067:264-269.
  • 7Izad M, Vodjgani M, Niknam MH, et al. Cytokines genes polymorphisms and risk of multiple sclerosis[J]. Am J Med Sci, 2010, 339(4) :327-331.
  • 8M/iurer M, Kruse N, Giess R, et al. Genetic variation at position --1082 of the interleukin 10 (ILl0) promotor and the outcome of multiple sclerosis[J].J Neuroimmunol, 2000, 104 (1) :98-100.
  • 9Mihailova S, Ivanova M, Mihaylova A, et al. Pro- and anti- inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients[J].J Neuroimmunol, 2005, 168(1-2) : 138-143.
  • 10Mirowska-Guzel D, Gromadzka G, Mach A, et al. Association of IL1A, IL1B, ILRN, IL6, ILl0 and TNF-alpha polymorphisms with risk and clinical course of multiple sclerosis in a Polish population[J]. J Neuroimmunol, 2011, 236(1/2) : 87-92.

二级参考文献3

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部